Nefazodone in patients with treatment-refractory posttraumatic stress disorder

Journal of Clinical Psychiatry

Volumn 61, Issue 3, 2000, Pages 203-208

  Zisook, Sidney ^a   Chentsova Dutton, Yulia E ^a   Smith Vaniz, Alison ^a   Kline, Neal A ^b   Ellenor, Gary L ^b   Kodsi, Angela B ^b   Gillin, J Christian ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; BUSPIRONE; CLONAZEPAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE MALEATE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; PHENELZINE; SERTRALINE; TRAZODONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; DIARRHEA; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; HEADACHE; HUMAN; HYPERTENSION; MALE; NAUSEA; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RATING SCALE; TREMOR; VERTIGO; VIET NAM; XEROSTOMIA;

EID: 0034004927     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0310     Document Type: Article

References (32)

1. Reist C, Kauffman CD, Haier RJ. A controlled trial of desipramine in 18 men with post-traumatic stress disorder. Am J Psychiatry 1989;146: 513-516
2. Davidson JRT, Kudler H, Smith R, et al. Treatment of post-traumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 1990;47: 259-266
3. Kosten TR, Wahby V, Giller E, et al. The dexamethasone suppression test and thyrolropin-releasing hormone stimulation test in PTSD. Biol Psychiatry 1990;28:657-664
4. Shestatzky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res 1988;24:149-155
5. van der Kolk BA, Dreyfuss D, Michaels M, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994;55:517-522
6. DeBoer M, Op de Velde W, Falger RJR, et al. Fluvoxamine treatment for chronic PTSD. Psychother Psychosom 1991;57:158-163
7. Marmar CR, Schoenfeld F, Weiss DS, et al. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry 1996;57(suppl 8):66-70
8. Rothbaum BO, Ninan PT, Thomas L. Sertraline in the treatment of rape victims with posttraumatic stress disorder. J Trauma Stress 1996;9: 865-871
9. Brady KT, Sonne SC, Roberts JM. Sertraline treatment of comorbid post-traumatic stress disorder and alcohol dependence. J Clin Psychiatry 1995; 56:502-505
10. Marshall RD, Schneier FR, Fallon BA, et al. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. J Clin Psychopharmacol 1998;18:10-18
11. Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry 1990;51:236-238
12. Gelpin E, Bonne O, Peri T, et al. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 1996;57:390-394
13. Kaplan Z, Amir M, Swartz M, et al. Inositol treatment of post-traumatic stress disorder. Anxiety 1996;2:51-52
14. Lipper S, Davidson JRT, Grady TA, et al. Preliminary study of carbamazepine in posttraumatic stress disorder. Psychosomatics 1986;27:849-854
15. Fesler FA. Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry 1991;52:361-364
16. Hertzberg MA, Feldman ME, Beckham JC, et al. Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol 1996;16:294-298
17. Fichtner CG, Cray ton JW. Buspirone in combat-related posttraumatic stress disorder [letter]. J Clin Psychopharmacol 1994;14:79-81
18. Forster PL, Schoenfeld FB, Marmar CR, et al. Lithium for irritability in posttraumatic stress disorder. J Trauma Stress 1995;8:143-149
19. Connor KM, Davidson JR, Weisler RH, et al. A pilot study of mirtazapine in post-traumatic stress disorder. Int Clin Psychopharmacol 1999;14: 29-31
20. Canive JM, Clark RD, Calais LA, et al. Bupropion treatment in veterans with posttraumatic stress disorder: an open study. J Clin Psychopharmacol 1998;18:379-383
21. Hidalgo R, Hertzberg MA, Mellman J, et al. Nefazodone in post-traumatic stress disorder: results from six open-label trials. Int Clin Psychopharmacol 1999;14:61-68
22. Sheehan DV, Lecrubier Y, Sheehan K, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997;12:232-241
23. Blake DD, Weathers FW, Nagy LM, et al. The development of a clinician-administered PTSD scale. J Trauma Stress 1995;8:75-90
24. Beck A, Ward C, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
25. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
26. Sheehan DV. The Anxiety Disease. New York, NY: Scribner; 1983
27. Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213
28. Davidson J. The clinical management of posttraumatic stress disorder. Federal Practitioner Supplement; 1997;14(75):15-17
29. Feiger A, Kiev A, Shrivastava RK, et al. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996;57 (suppl 2):53-62
30. Gillin JC, Rapaport M, Erman MK, et al. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. J Clin Psychiatry 1997;58:185-192. Correction 1997;58:275
31. Gillin JC, Rapaport M, Erman MK, et al. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. J Clin Psychiatry 1997;58:185-192. Correction 1997;58:275
32. Mellman T. The biology of posttraumatic stress disorder and related sleep disturbance. Federal Practitioner Supplement 1997;14(75):25-29